However, RNF2, PCGF2, and CBX2/4/8 expression was higher in all four breast cancer stages compared to normal breast tissue, suggesting that their overexpression was not predictive of breast cancer aggressiveness (Supplementary Fig. 2b). Here, CBX2 is linked to breast carcinoma.